Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ucommune International (UK) Notes Payables (2019 - 2023)

Ucommune International has reported Notes Payables over the past 5 years, most recently at $109000.0 for Q2 2023.

  • For Q2 2023, Notes Payables fell 97.94% year-over-year to $109000.0; the TTM value through Jun 2023 reached $109000.0, down 97.94%, while the annual FY2022 figure was $2.5 million, 66.23% down from the prior year.
  • Notes Payables for Q2 2023 was $109000.0 at Ucommune International, down from $111077.2 in the prior quarter.
  • Over five years, Notes Payables peaked at $19.7 million in Q4 2019 and troughed at $109000.0 in Q2 2023.
  • A 5-year average of $8.7 million and a median of $9.3 million in 2021 define the central range for Notes Payables.
  • Biggest five-year swings in Notes Payables: increased 0.13% in 2021 and later plummeted 98.51% in 2022.
  • Year by year, Notes Payables stood at $19.7 million in 2019, then tumbled by 62.06% to $7.5 million in 2020, then grew by 0.13% to $7.5 million in 2021, then plummeted by 98.51% to $111077.2 in 2022, then dropped by 1.87% to $109000.0 in 2023.
  • Business Quant data shows Notes Payables for UK at $109000.0 in Q2 2023, $111077.2 in Q4 2022, and $5.3 million in Q2 2022.